New: ntla

nadzry (25)in crispr • 7 years ago
Analyst outperform ratings on Crispr stocks.
Cowen, Barclays and ROTH all host healthcare conferences next week; • Intellia Therapeutics (NASDAQ:NTLA) initiated with Outperform rating and $76 (158% upside) price target at JMP Securities. •…
Downvoting a post can decrease pending rewards and make it less visible. Common reasons:
Disagreement on rewards
Fraud or plagiarism
Hate speech or trolling
Miscategorized content or spam

Submit
$0.00
0